[1]
Kwiatkowska-Borowczyk, E.P. et al. 2014. Adoptive transfer of tumor specific T cells from allogeneic donors is feasible, effective and safe alternative to autologous T cell based tumor immunotherapy. Journal of Medical Science. 83, 1 (Mar. 2014), 21–28. DOI:https://doi.org/10.20883/medical.e39.